Skip to main content
. Author manuscript; available in PMC: 2013 Apr 8.
Published in final edited form as: Cell Cycle. 2009 Jul 23;8(14):2266–2280. doi: 10.4161/cc.8.14.9101

Figure 5.

Figure 5

VEGFR-3 increases proliferation of breast cancer cells. BrdU incorporation was measured after 24 hours in fluorogenic enzyme immunoassay. (A) MCF7-VEGFR-3 proliferation compared to MCF7-pcDNA3 proliferation. (B) Proliferation of MCF7-VEGFR3 shRNA clones. (C) BT474 cells treated with VEGFR-3-specific siRNA and Control siRNA (10 nM) for 48 h and analyzed after 24 h of BrdU incorporation (*p = 0.0019). (D) Proliferation of BT474 in comparison with BT474 shRNA clones. **p < 0.001, RFU—relative fluorescent units.